BASEN Side Effects

6305196-2 | Hypoglycaemia, Psychiatric Symptom, Road Traffic Accident
on Aug 01, 2009 Male patient from JAPAN , 55 years of age, was diagnosed with gastritis, insomnia and was treated with Basen (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, psychiatric symptom, road traffic accident. Basen dosage: Unk. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MYSLEE (View Myslee Review and Myslee Label ).

6280053-9 | Hypoglycaemia, Psychiatric Symptom, Road Traffic Accident
Patient was taking Basen (View Usage). Patient had the following side effects: hypoglycaemia, psychiatric symptom, road traffic accident on Jul 10, 2009 from JAPAN Additional patient health information: Male patient , 55 years of age, . Basen dosage: Unk. During the same period patient was treated with GASTER (View Gaster Review and Gaster Label ), MYSLEE (View Myslee Review and Myslee Label ).

5863456-3 | Bradycardia
Adverse event was reported on Aug 18, 2008 by a Male patient taking Basen (View Usage) (Dosage: ) was diagnosed with cerebral infarction and. Location: JAPAN , 74 years of age, weighting 166.4 lb, After Basen was administered, patient had the following side effects: bradycardia. During the same period patient was treated with EPADEL (3 Df) (View Epadel Review and Epadel Label ), LASIX (View Lasix Review and Lasix Label ), KINEDAK (View Kinedak Review and Kinedak Label ), PLAVIX (View Plavix Review and Plavix Label ), HUMACART N (34-0-14) (View Humacart N Review and Humacart N Label ). Patient was hospitalized.

5426294-1 | Cataract, Glaucoma
on Aug 16, 2007 Male patient from JAPAN , weighting 147.7 lb, was diagnosed with gastritis, cerebral infarction and was treated with Basen (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), glaucoma (What is glaucoma?). Basen dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), PLAVIX (View Plavix Review and Plavix Label ), KETAS (View Ketas Review and Ketas Label ). Patient was hospitalized.


5412623-1 | Cataract, Glaucoma
on Aug 06, 2007 Male patient from JAPAN , weighting 154.3 lb, was diagnosed with gastritis, cerebral infarction and was treated with Basen (View Usage). Patient had the following side effects: cataract (What is cataract?), glaucoma (What is glaucoma?). Basen dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), PLAVIX (View Plavix Review and Plavix Label ), KETAS (View Ketas Review and Ketas Label ). Patient was hospitalized.

5406313-9 | Cataract, Glaucoma, Visual Acuity Reduced
Patient was taking Basen (View Usage). After Basen was administered, patient had the following side effects: cataract (What is cataract?), glaucoma (What is glaucoma?), visual acuity reduced on Jul 30, 2007 from JAPAN Additional patient health information: Male patient , weighting 154.3 lb, was diagnosed with gastritis, cerebral infarction and. Basen dosage: . During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), PLAVIX (View Plavix Review and Plavix Label ), KETAS (View Ketas Review and Ketas Label ). Patient was hospitalized.

5384325-1 | Cataract, Glaucoma, Vision Blurred
Adverse event was reported on Jun 29, 2007 by a Male patient taking Basen (View Usage) (Dosage: ) was diagnosed with cerebral infarction and. Location: JAPAN , 61 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), glaucoma (What is glaucoma?), vision blurred. During the same period patient was treated with MUCOSTA (View Mucosta Review and Mucosta Label ), KETAS (View Ketas Review and Ketas Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5122565-7 |
on Sep 20, 2006 Female patient from JAPAN , 70 years of age, weighting 136.7 lb, was diagnosed with hypertension and was treated with Basen (View Usage). . Basen dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), AMARYL (View Amaryl Review and Amaryl Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ).

5114531-2 |
on Sep 20, 2006 Female patient from JAPAN , 70 years of age, weighting 136.7 lb, was diagnosed with hypertension and was treated with Basen (View Usage). . Basen dosage: . During the same period patient was treated with NORVASC (View Norvasc Review and Norvasc Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), AMARYL (View Amaryl Review and Amaryl Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ).

5061338-0 | Anti-insulin Antibody Positive, Blood Glucose Fluctuation
Patient was taking Basen (View Usage). Patient experienced the following unwanted or unexpected effects: anti-insulin antibody positive, blood glucose fluctuation on Jul 03, 2006 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus, gastritis, hypertension, transient ischaemic attack and. Basen dosage: .9 Mg, Qd. During the same period patient was treated with NOVORAPID 30 MIX CHU FLEXPEN (18-26 Iu) (View Novorapid 30 Mix Chu Flexpen Review and Novorapid 30 Mix Chu Flexpen Label ), NOVORAPID CHU FLEXPEN (12-20 Iu, Qd) (View Novorapid Chu Flexpen Review and Novorapid Chu Flexpen Label ), NOVOLIN N (6 Iu, Unk) (View Novolin N Review and Novolin N Label ), SELBEX (100 Mg, Qd) (View Selbex Review and Selbex Label ), AMLODIN (5 Mg, Qd) (View Amlodin Review and Amlodin Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5051151-2 | Anti-insulin Antibody Positive, Hyperglycaemia, Hypoglycaemia
Adverse event was reported on May 29, 2006 by a Female patient taking Basen (View Usage) (Dosage: .9 Mg, Qd) was diagnosed with insulin-requiring type ii diabetes mellitus and. Location: JAPAN , 77 years of age, weighting 110.2 lb, Patient had the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. During the same period patient was treated with INNOLET 30R CHU (26 Iu, Qd) (View Innolet 30r Chu Review and Innolet 30r Chu Label ), NOVORAPID 30 MIX CHU FLEXPEN (26 Iu, Qd) (View Novorapid 30 Mix Chu Flexpen Review and Novorapid 30 Mix Chu Flexpen Label ), NOVOLIN R (28 Iu, Prn) (View Novolin R Review and Novolin R Label ), URSO (300 Mg, Unk) (View Urso Review and Urso Label ), ADALAT (40 Mg, Qd) (View Adalat Review and Adalat Label ), BLOPRESS (8 Mg, Qd) (View Blopress Review and Blopress Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), MAGNESIUM /00552801/ (1 G, Unk) (View Magnesium /00552801/ Review and Magnesium /00552801/ Label ). Patient was hospitalized.

5044138-7 | Anti-insulin Antibody Positive, Hyperglycaemia, Hypoglycaemia
on May 29, 2006 Female patient from JAPAN , 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Basen (View Usage). After Basen was administered, patient had the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. Basen dosage: .9 Mg, Qd. During the same period patient was treated with INNOLET 30R CHU (26 Iu, Qd) (View Innolet 30r Chu Review and Innolet 30r Chu Label ), NOVORAPID 30 MIX CHU FLEXPEN (26 Iu, Qd) (View Novorapid 30 Mix Chu Flexpen Review and Novorapid 30 Mix Chu Flexpen Label ), NOVOLIN R (28 Iu, Prn) (View Novolin R Review and Novolin R Label ), URSO (300 Mg, Unk) (View Urso Review and Urso Label ), ADALAT (40 Mg, Qd) (View Adalat Review and Adalat Label ), BLOPRESS (8 Mg, Qd) (View Blopress Review and Blopress Label ), ASPIRIN (100 Mg, Qd) (View Aspirin Review and Aspirin Label ), MAGNESIUM /00552801/ (1 G, Unk) (View Magnesium /00552801/ Review and Magnesium /00552801/ Label ). Patient was hospitalized.

4832799-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Chills, Feeling Cold, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise
on Oct 13, 2005 Female patient from JAPAN , 57 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia, nail tinea, nasopharyngitis, stomach discomfort and was treated with Basen (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, chills, feeling cold, gamma-glutamyltransferase increased, hepatic function abnormal, malaise. Basen dosage: 0.9 Mg/d. During the same period patient was treated with AMARYL (4 Mg/d) (View Amaryl Review and Amaryl Label ), MELBIN (750 Mg/d) (View Melbin Review and Melbin Label ), LIPITOR (10 Mg/d) (View Lipitor Review and Lipitor Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ), FLOMOX (View Flomox Review and Flomox Label ), ACINON (View Acinon Review and Acinon Label ), STROCAIN (View Strocain Review and Strocain Label ), PL GRAN. (View Pl Gran. Review and Pl Gran. Label ). Patient was hospitalized.

4826368-X | Electrocardiogram Qt Prolonged
Patient was taking Basen (View Usage). Patient had the following side effects: electrocardiogram qt prolonged on Nov 10, 2005 from JAPAN Additional patient health information: Male patient , 57 years of age, . Basen dosage: 0.9 Mg, Unk. During the same period patient was treated with URSODEOXYCHOLIC ACID (300 Mg, Unk) (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), GASCON (120 Mg, Unk) (View Gascon Review and Gascon Label ), NEUROVITAN (3 Df, Unk) (View Neurovitan Review and Neurovitan Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ).

4807172-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Chills, Feeling Cold, Gamma-glutamyltransferase Increased, Malaise
Adverse event was reported on Oct 13, 2005 by a Female patient taking Basen (View Usage) (Dosage: ) was diagnosed with nail tinea and. Location: JAPAN , 57 years of age, After Basen was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chills, feeling cold, gamma-glutamyltransferase increased, malaise. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), MELBIN (View Melbin Review and Melbin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LAMISIL (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

4769933-0 | Blood Albumin Decreased, Concomitant Disease Progression, Dyspnoea, Fluid Retention, Nephrotic Syndrome, Pleural Effusion, Protein Total Decreased, Renal Impairment
on Apr 27, 2005 Female patient from JAPAN , 52 years of age, weighting 141.1 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia and was treated with Basen (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, concomitant disease progression, dyspnoea, fluid retention, nephrotic syndrome, pleural effusion, protein total decreased, renal impairment. Basen dosage: . During the same period patient was treated with GLIMICRON (View Glimicron Review and Glimicron Label ), LOCHOL (View Lochol Review and Lochol Label ). Patient was hospitalized.

4745859-3 | Blood Albumin Decreased, Concomitant Disease Progression, Dyspnoea, Fluid Retention, Nephrotic Syndrome, Pleural Effusion, Protein Total Decreased, Renal Impairment
on Apr 27, 2005 Female patient from JAPAN , 52 years of age, weighting 141.1 lb, was diagnosed with diabetes mellitus, hypercholesterolaemia and was treated with Basen (View Usage). Patient had the following side effects: blood albumin decreased, concomitant disease progression, dyspnoea, fluid retention, nephrotic syndrome, pleural effusion, protein total decreased, renal impairment. Basen dosage: . During the same period patient was treated with GLIMICRON (View Glimicron Review and Glimicron Label ), LOCHOL (View Lochol Review and Lochol Label ). Patient was hospitalized.

4680990-2 | Diabetes Mellitus Inadequate Control, Hypoglycaemia, Meningitis Viral, Tremor
Patient was taking Basen (View Usage). After Basen was administered, patient had the following side effects: diabetes mellitus inadequate control, hypoglycaemia, meningitis viral, tremor on Jun 30, 2004 from Additional patient health information: Female patient , 62 years of age, was diagnosed with diabetes mellitus, prophylaxis and. Basen dosage: 0.6 Mg, Unk. During the same period patient was treated with PHENYTOIN (200 Mg, Qd) (View Phenytoin Review and Phenytoin Label ), GASTER (20 Mg) (View Gaster Review and Gaster Label ), STARSIS #AJ (270 Mg, Qd) (View Starsis #aj Review and Starsis #aj Label ). Patient was hospitalized.

4577160-5 | Diabetes Mellitus Inadequate Control, Hypoglycaemia, Meningitis Viral, Tremor
Adverse event was reported on Jun 30, 2004 by a Female patient taking Basen (View Usage) (Dosage: 0.2 Mg, Tid) was diagnosed with blood glucose increased, prophylaxis, diabetes mellitus and. Location: , 62 years of age, Patient experienced the following unwanted or unexpected effects: diabetes mellitus inadequate control, hypoglycaemia, meningitis viral, tremor. During the same period patient was treated with PHENYTOIN (200 Mg/day) (View Phenytoin Review and Phenytoin Label ), GASTER (20 Mg) (View Gaster Review and Gaster Label ), STARSIS #AJ (270 Mg/day) (View Starsis #aj Review and Starsis #aj Label ). Patient was hospitalized.